Lamisil by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC Drug Facts

Lamisil by

Drug Labeling and Warnings

Lamisil by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

LAMISIL AT JOCK ITCH- terbinafine hydrochloride cream 
Haleon US Holdings LLC

----------

Drug Facts

Active ingredient

Terbinafine hydrochloride 1%

Purpose

Antifungal

Uses

  • cures most jock itch (tinea cruris) and ringworm (tinea corporis)
  • relieves itching, burning, cracking and scaling which accompany these conditions

Warnings

For external use only

Do not use

  • on nails or scalp
  • in or near the mouth or eyes
  • for vaginal yeast infections

When using this product

do not get into eyes. If eye contact occurs, rinse thoroughly with water.

Stop use and ask doctor if

too much irritation occurs or gets worse

Keep out of reach of children

If swallowed, get medical help or contact a poison control center right away.

Directions

  • adults and children 12 years and over:
    • use the tip of the cap to break the seal and open the tube
    • wash the affected skin with soap and water and dry completely before applying
    •  apply once a day (morning  or  night) for 1 week or as directed by a doctor
    • wash hands after each use
  • children under 12 years: ask a doctor

Other information

  • do not use if seal on tube is broken or is not visible
  • store at controlled room temperature 20-25°C (68-77°F)

Inactive ingredients

benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

Questions or comments?

call 1-800-330-9876

Distributed by: GSK Consumer Healthcare, Warren, NJ 07059

Trademarks owned or licensed by GSK.

©2019 GSK or licensor.

13510 (Front Carton)

Principal Display Panel

NDC 0067-3999-42

LAMISIL AT CREAM

gsk

TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL

FOR JOCK ITCH

NET WT 12 g (0.42 oz)

13510 (Front Carton)

13510 Lamisil AT JI 12g (0.42 oz)
LAMISIL  AT JOCK ITCH
terbinafine hydrochloride cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 0067-3999
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE HYDROCHLORIDE10 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
BENZYL ALCOHOL (UNII: LKG8494WBH)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
CETYL PALMITATE (UNII: 5ZA2S6B08X)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
POLYSORBATE 60 (UNII: CAL22UVI4M)  
WATER (UNII: 059QF0KO0R)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)  
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 0067-3999-421 in 1 CARTON12/08/200612/31/2022
112 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02098012/08/200612/31/2022
Labeler - Haleon US Holdings LLC (079944263)

Revised: 3/2024
 

Trademark Results [Lamisil]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LAMISIL
LAMISIL
85528483 4256554 Live/Registered
Novartis AG
2012-01-30
LAMISIL
LAMISIL
77394986 not registered Dead/Abandoned
Novartis AG
2008-02-12
LAMISIL
LAMISIL
73786484 1567931 Live/Registered
SANDOZ AG (SANDOZ LTD., SANDOZ S.A.)
1989-03-13
LAMISIL
LAMISIL
73769411 not registered Dead/Abandoned
SANDOZ PHARMACEUTICALS CORPORATION
1988-12-14

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.